NOVAVAX INC (NVAX) › Shareholders' EquityNOVAVAX INC (NVAX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2008: $42.95M2009: $69.95M2010: $59.05M2011: $53.85M2012: $80.24M2013: $203.23M2014: $229.62M2015: $292.67M2016: -$5.55M2017: -$101.73M2018: -$167.94M2019: -$186.02M2020: $627.21M2021: -$351.67M2022: -$634.08M2023: -$716.93M2024: -$623.84M2025: -$127.75M-$127.75M2008Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$127.75M+79.5%2024-$623.84M+13.0%2023-$716.93M-13.1%2022-$634.08M-80.3%2021-$351.67M-156.1%2020$627.21M+437.2%2019-$186.02M-10.8%2018-$167.94M-65.1%2017-$101.73M-1734.3%2016-$5.55M-101.9%2015$292.67M+27.5%2014$229.62M+13.0%2013$203.23M+153.3%2012$80.24M+49.0%2011$53.85M-8.8%2010$59.05M-15.6%2009$69.95M+62.9%2008$42.95M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share